CCP
EW icon

Corient Capital Partners’s Edwards Lifesciences EW Stock Holding History

Corient Capital Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.07M Buy
11,263
+414
+4% +$39.8K 0.08% 211
2022
Q2 		$1.03M Buy
10,849
+1,000
+10% +$104K 0.08% 224
2022
Q1 		$1.16M Buy
9,849
+657
+7% +$73.7K 0.08% 225
2021
Q4 		$1.19M Sell
9,192
-7,736
-46% -$902K 0.08% 209
2021
Q3 		$1.92M Sell
16,928
-1,925
-10% -$220K 0.14% 143
2021
Q2 		$1.95M Buy
18,853
+3,367
+22% +$317K 0.14% 137
2021
Q1 		$1.3M Buy
15,486
+8,463
+121% +$715K 0.11% 169
2020
Q4 		$641K Buy
7,023
+218
+3% +$18.1K 0.06% 240
2020
Q3 		$543K Sell
6,805
-158
-2% -$12.3K 0.06% 246
2020
Q2 		$481K Buy
6,963
+672
+11% +$47.8K 0.06% 253
2020
Q1 		$395K Sell
6,291
-759
-11% -$54.7K 0.06% 256
2019
Q4 		$549K Buy
7,050
+327
+5% +$25.5K 0.07% 269
2019
Q3 		$492K Buy
6,723
+1,575
+31% +$111K 0.07% 265
2019
Q2 		$317K Buy
5,148
+354
+7% +$21.4K 0.05% 296
2019
Q1 		$306K Buy
+4,794
New +$274K 0.05% 278

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Corient Capital Partners's EW Position: Q3 2022 in Review

Corient Capital Partners increased its Edwards Lifesciences (EW) stake by 3.8% in Q3 2022, buying an estimated $39.8K and bringing the position to 11,263 shares worth $1.07M. The position accounts for 0.08% of the portfolio, ranked #211.

Corient Capital Partners first reported a position in EW in Q1 2019 and has held it in 15 quarters since. The position peaked at $1.95M in Q2 2021. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.

  • Corient Capital Partners held 11,263 shares of Edwards Lifesciences worth $1.07M as of Q3 2022.
  • Corient Capital Partners bought 414 Edwards Lifesciences shares in Q3 2022, an estimated $39.8K.
  • Edwards Lifesciences made up 0.08% of Corient Capital Partners's portfolio in Q3 2022, its #211 holding.
  • Corient Capital Partners first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 15 quarters since.
  • Corient Capital Partners's Edwards Lifesciences position peaked at $1.95M in Q2 2021.
  • 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.